hVIVO PLC (LSE:HVO) - Share price - Overview

Stock Report

hVIVO PLC HVO

Last Price
GBX54.50

Day Change
0.00|0.00%

As of 12/01/2018
08:11:28 GMT | GBX
Minimum 15 Minutes Delay.

Last Close54.50p
Day Range50.50 - 50.50
Mkt Cap42.62Mil
52-Wk Range47.00 - 239.75
Yield %0.00
ISINGB00B6ZM0X53
Volume5,649
P/E-2.53
P/S2.14
P/CF-2.43

Share Price

Total Returns 15/01/2018

 Chg (%)  
More ...
hVIVO PLC0.93 
FTSE 100 TR GBP3.81
 
Financials
201420152016
More ...
Income Statement
Turnover18.477.7219.85
Operating Profit-23.05-22.00-22.92
Net Profit-18.44-17.91-17.88
Reported EPS-31.30-26.00-22.90
Balance Sheet
Current Assets61.2763.0635.93
Non Current Assets8.2121.6920.80
Total Assets69.4884.7456.73
Current Liabilities4.6217.507.14
Total Liabilities8.3021.1210.67
Total Equity61.1863.6246.05
Cash Flow
Operating Cash Flow-19.15-13.60-22.39
Net Change in Cash9.52-8.6311.47
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-13.40-10.90--5.00---
2018-13.30-12.80--4.26---

Regulatory News

DateSourceHeadline
More ...
16/01/2018|07:00RNShVIVO plc - Award of Share Options
09/01/2018|07:00RNShVIVO plc - Directors' Dealings
21/12/2017|07:00RNShVIVO plc - Award of Share Options
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/01/2018PurchaseMr Jaime Ellertson55.0016,4019,021.00
11/01/2018PurchaseMr. Jim Winschel55.007,2744,001.00
14/12/2017PurchaseDr. Trevor Phillips56.009,0355,060.00
09/10/2017PurchaseMr Jaime Ellertson75.0017,86313,397.00

Company Profile

hVIVO PLC is a specialty biopharma company. It provides technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases.

Sector

Biotechnology

Market Position

1173 of 1837 Companies

Index

Outlook

(21/09/2017) "...we currently believe that our revenue and gross margin will be in line with market expectations"

Next Event 20/04/2018

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)-4.2614.0216.61
Div Yld (E)0.004.064.01
PEG (E)0.00-0.671.19
ROCE-48.94181.5818.22
Op Mrgn-73.12-9.150.66
EPS Grwth0.006.4912.61
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Trevor Phillips
Chief Executive OfficerKym Denny
Chief Financial & Business Officer & CSGraham Yeatman
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.